Inventor · disambiguated record
Anthony Futerman
Also filed as: FUTERMAN ANTHONY · FUTERMAN ANTHONY H
6 granted patents·8 pending applications·2 citations·filing 2003–2024
70Inventor score
Top patents by PatentIndex Score
14 records- 0185US2025186565A1Ceramide levels in the treatment and prevention of infectionsICAHN SCHOOL MED MOUNT SINAI·Filed 2024·Application pending·0 cites
- 0270US2022202919A1Ceramide levels in the treatment and prevention of infectionsICAHN SCHOOL MED MOUNT SINAI·Filed 2021·Application pending·0 cites
- 0365US7429460B2Methods of screening for inhibitors of phospholipid synthesis related to glycolipid-storage diseasesYEDA RES & DEV·Filed 2003·Granted Sep 30, 2008·1 cites·7 claims
- 0459US2019151424A1Ceramide levels in the treatment and prevention of infectionsICAHN SCHOOL MED MOUNT SINAI·Filed 2018·Application pending·0 cites
- 0558US11471430B2Sphingosine analogs and use thereof against bacterial lung infectionsYEDA RES & DEV·Filed 2019·Granted Oct 18, 2022·0 cites·9 claims
- 0658US10159724B2Ceramide levels in the treatment and prevention of infectionsICAHN SCHOOL MED MOUNT SINAI·Filed 2016·Granted Dec 25, 2018·0 cites·20 claims
- 0758US9492514B2Ceramide levels in the treatment and prevention of infectionsICAHN SCHOOL MED MOUNT SINAI·Filed 2013·Granted Nov 15, 2016·0 cites·18 claims
- 0849US2023132790A1Variants of beta-glucocerebrosidase for use in treating gaucher diseaseYEDA RES & DEV·Filed 2021·Application pending·0 cites
- 0946US2015258043A1Use of sphingoid long chain bases and their analogs in treating and preventing bacterial infectionsYEDA RES & DEV·Filed 2013·Application pending·0 cites
- 1045US7855063B2Partially deglycosylated glucocerebrosidase polypeptide and crystals thereofYEDA RES & DEV·Filed 2004·Granted Dec 21, 2010·1 cites·2 claims
- 1140US10265412B2Enzyme replacement therapy for treating lysosomal storage diseasesSTERN NAFTALI·Filed 2007·Granted Apr 23, 2019·0 cites·16 claims
- 1239US2016051629A1Inhibition of rip kinases for treating lysosomal storage diseasesYEDA RES & DEV·Filed 2014·Application pending·0 cites
- 1335US2017030926A1Marker of neuropathic gaucher's disease and methods of use thereofYEDA RES & DEV·Filed 2016·Application pending·0 cites
- 1430US2017273917A1Nmda receptor antagonists for treating gaucher diseaseYEDA RES & DEV·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →